AU3898000A - Treatment of neuropathic pain or fibromyalgia - Google Patents
Treatment of neuropathic pain or fibromyalgiaInfo
- Publication number
- AU3898000A AU3898000A AU38980/00A AU3898000A AU3898000A AU 3898000 A AU3898000 A AU 3898000A AU 38980/00 A AU38980/00 A AU 38980/00A AU 3898000 A AU3898000 A AU 3898000A AU 3898000 A AU3898000 A AU 3898000A
- Authority
- AU
- Australia
- Prior art keywords
- fibromyalgia
- treatment
- neuropathic pain
- neuropathic
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000001640 Fibromyalgia Diseases 0.000 title 1
- 208000004296 neuralgia Diseases 0.000 title 1
- 208000021722 neuropathic pain Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12511399P | 1999-03-19 | 1999-03-19 | |
| US60125113 | 1999-03-19 | ||
| PCT/US2000/007204 WO2000056318A1 (en) | 1999-03-19 | 2000-03-17 | Treatment of neuropathic pain or fibromyalgia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3898000A true AU3898000A (en) | 2000-10-09 |
Family
ID=22418242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU38980/00A Abandoned AU3898000A (en) | 1999-03-19 | 2000-03-17 | Treatment of neuropathic pain or fibromyalgia |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU3898000A (en) |
| WO (1) | WO2000056318A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6476078B2 (en) | 1999-08-11 | 2002-11-05 | Sepracor, Inc. | Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction |
| US6974838B2 (en) | 1998-08-24 | 2005-12-13 | Sepracor Inc. | Methods of treating or preventing pain using sibutramine metabolites |
| US6399826B1 (en) | 1999-08-11 | 2002-06-04 | Sepracor Inc. | Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain |
| US6610887B2 (en) | 2001-04-13 | 2003-08-26 | Sepracor Inc. | Methods of preparing didesmethylsibutramine and other sibutramine derivatives |
| US6635675B2 (en) | 2001-11-05 | 2003-10-21 | Cypress Bioscience, Inc. | Method of treating chronic fatigue syndrome |
| TWI438190B (en) * | 2008-07-24 | 2014-05-21 | Theravance Inc | 3-(phenoxyphenylmethyl)pyrrolidine compounds |
| WO2014149819A1 (en) | 2013-03-14 | 2014-09-25 | Kalyra Pharmaceuticals, Inc. | Bicyclic analgesic compounds |
| JP6542794B2 (en) | 2013-12-12 | 2019-07-10 | ゼノ ロイアルティー アンド マイルストーンズ リミテッド ライアビリティー カンパニー | Bicyclic alkyl compounds, and synthesis |
| CN113336653A (en) | 2014-03-07 | 2021-09-03 | 里科瑞尔姆Ip控股有限责任公司 | Propalane derivatives and synthesis |
| CA2961605C (en) | 2014-09-17 | 2023-01-10 | Kalyra Pharmaceuticals, Inc. | Bicyclic compounds |
| US20190060257A1 (en) * | 2016-03-16 | 2019-02-28 | Zeno Royalties & Milestones, LLC | Analgesic compounds |
| WO2018213140A1 (en) | 2017-05-15 | 2018-11-22 | Zeno Royalties & Milestones, LLC | Analgesic compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2675573B2 (en) * | 1988-03-31 | 1997-11-12 | 科研製薬株式会社 | Brain function improver |
-
2000
- 2000-03-17 AU AU38980/00A patent/AU3898000A/en not_active Abandoned
- 2000-03-17 WO PCT/US2000/007204 patent/WO2000056318A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000056318A1 (en) | 2000-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7906100A (en) | Use of retigabin for treating neuropathic pain | |
| GB9824436D0 (en) | Methods of treatment | |
| AU3784999A (en) | Methods for treatment of pain | |
| AU3898000A (en) | Treatment of neuropathic pain or fibromyalgia | |
| AU2740899A (en) | Treatment of liquids | |
| AU3896900A (en) | Treatment of pain | |
| AU2512501A (en) | Use of trimebutine for treating pain | |
| AU7756900A (en) | Treatment of chemical hydrolysates | |
| AU2566201A (en) | Compounds and methods for the treatment of pain | |
| AU2420101A (en) | Method and composition for the treatment of pain | |
| AU5824800A (en) | Use of fosphenytoin for the treatment of acute neuropathic pain | |
| AU4598400A (en) | Method of treatment | |
| AU2619199A (en) | Treatment of waxes | |
| AU2683500A (en) | Compositions for the treatment of pain | |
| AU2420201A (en) | Compounds and methods for the treatment of pain | |
| AU2382601A (en) | Novel method of treatment | |
| AU6112299A (en) | Treatment of effluents | |
| AU8557598A (en) | Treatment of fluids | |
| AU2002315238A1 (en) | Treatment of neuropathic pain | |
| AUPQ421299A0 (en) | Treatment of bone disorder | |
| AUPP571098A0 (en) | Method of treatment of animals | |
| AU4014800A (en) | Treatment of gallstones | |
| AU5294499A (en) | Treatment of hair loss | |
| AUPQ385599A0 (en) | Treatment of hypercholesterolaemia | |
| AUPQ320299A0 (en) | Method of treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |